Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03AYF
|
||||
Former ID |
DNC010403
|
||||
Drug Name |
3-chlorophenyl 4-butoxybenzylcarbamate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530604] | ||
Structure |
Download2D MOL |
||||
Formula |
C18H20ClNO3
|
||||
Canonical SMILES |
CCCCOC1=CC=C(C=C1)CNC(=O)OC2=CC(=CC=C2)Cl
|
||||
InChI |
1S/C18H20ClNO3/c1-2-3-11-22-16-9-7-14(8-10-16)13-20-18(21)23-17-6-4-5-15(19)12-17/h4-10,12H,2-3,11,13H2,1H3,(H,20,21)
|
||||
InChIKey |
RFAALCRYXIMHGO-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530604] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.